Swissmedic collaborates with NZ counterpart on drug regulation
This article was originally published in SRA
The Swiss agency for therapeutic products, Swissmedic, has signed an agreement with its New Zealand counterpart, Medsafe, to co-operate on the regulation of drugs and medical devices1.
You may also be interested in...
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.